CEL-SCI Corporation (CVM):
Important Stats for Investors:
CEL-SCI Corporation (CVM) shares jumped 11.06 percent and closed the day at $2.21. The Relative Volume value measured for CEL-SCI Corporation stands at 3.33. A total of 586183 shares exchanged at hands and its Average Volume is 176.22 Million. Its 52-week high and low range is $3.69 and $0.06, respectively. The company has a market cap of $26.41 Million.
The SMA20 for the stock is at 16.55 percent, SMA50 stands at 20.97 percent, while SMA200 is 6.74 Percent, according to Finviz reported data. Return on Assets (ROA) value of the stock is -64.1 Percent. The Return on Equity (ROE) and Return on Investment (ROI) values are 880 percent and 0 percent respectively.
The stock currently shows its YTD (Year to Date) performance of 16.94 percent, whereas its Weekly performance stands at 12.18%. The Monthly and Yearly performances are 16.54 percent and -41.07 percent respectively.
Profitability and Ratings Review:
Profitability analysis greatly helps in making investment decision. Net profit margin of CEL-SCI Corporation (CVM) was recorded at 0 percent, operating profit margin was 0 percent, while gross profit margin stands at 0 percent. Beta factor was calculated at -1.68.
Looking at the Analyst Recommendations of the stock, 0 Analysts issued a Buy for MoSys, 0 gave Outperform, 1 analysts gave Hold Rating, 0 issued Underperform and 0 marked the stock as Sell.
The company’s Average Earnings Estimate for the Current Fiscal quarter is $-1.04, according to consensus of 1 analysts. They are also projecting the Low EPS estimate of $-1.04 and the High EPS estimate of $-1.04.
The company’s Average Revenue Estimate for the current quarter is $1.5 Million, while Low and High Revenue Estimates are $1.5 Million and $1.5 Million respectively. These Revenue projections are a consensus of 1 Analysts.
Volatility is a key factor to observe. When we see the company’s Volatility, it currently has a monthly volatility of 5.99% and weekly volatility of 7.34%.
Actinium Pharmaceuticals, Inc. (ATNM):
Last Day Trading Summary:
The Company ended its previous trading session at $0.73 with the gain of 3.08%. The market capitalization of the company is $58.3 Million. Overall, 585903 shares exchanged hands versus its average volume of $887.76 Million. Actinium Pharmaceuticals, Inc. currently has its 52-Week High range of $1.72, while its 52-week low range is $0.54. The Price to Sales (P/S) of the company is 0, while P/B (Price to Book) stands at 2.92. By looking at the Volatility of the company, Week Volatility is at 4.43%, whereas Month Volatility stands at 5.79%.
Looking at Recommendation Trends of the stock polled by Reuters. For the Current month, 0 analysts have assigned this stock as Buy where 4 assigned Outperform, 0 analysts believe it’s a Hold, 0 said Underperform and only 0 assigned Sell rating.
For the current Fiscal Quarter, 3 analysts on average are expecting earnings of $-0.08 per share. According to the Analysts, the Low Estimate Earnings of the current Quarter is $-0.09 whereas, High Estimate is $-0.07.
According to 2 analysts, the Average Revenue Estimate is $0 for the current Fiscal quarter. The Low Revenue estimate is $0, while High Revenue estimate is $0.